Adicet Bio Inc (NASDAQ:ACET)’s traded shares stood at 1.28 million during the latest session, with the company’s beta value hitting 1.97. At the last check today, the stock’s price was $0.88, to imply a decrease of -2.01% or -$0.02 in intraday trading. The ACET share’s 52-week high remains $2.54, putting it -188.64% down since that peak but still an impressive 7.95% since price per share fell to its 52-week low of $0.81.
Analysts have given a consensus recommendation of Buy for Adicet Bio Inc (ACET), translating to a mean rating of 1.50. Of 2 analyst(s) looking at the stock, 0 analyst(s) give ACET a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.35.
Adicet Bio Inc (NASDAQ:ACET) trade information
After registering a -2.01% downside in the latest session, Adicet Bio Inc (ACET) has traded red over the past five days. The 5-day price performance for the stock is -11.58%, and -1.11% over 30 days. With these gigs, the year-to-date price performance is -8.09%.
The extremes give us $27 and $38 for target low and target high price respectively. As such, ACET has been trading -4218.18% off suggested target high and -2968.18% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 19.75% for the past 5-year period. While 2025 is set for a 51.96% return in earnings, projections for the next 5 years are at 22.99% annually.
ACET Dividends
Adicet Bio Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is TANG CAPITAL MANAGEMENT LLC with 8.22 million shares, or about 9.0663% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $9.94 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Adicet Bio Inc (ACET) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 2.07 shares. This is just over 2.51% of the total shares, with a market valuation of $1.82 million. Data from the same date shows that the other fund manager holds a little less at 1.08, or 1.31% of the shares, all valued at about 0.95 million.
